iifl-logo

Remus Pharmaceuticals Ltd Share Price Live

Add as a Preferred Source on Google
₹1,011.55
(-0.90%)
Oct 15, 2026|03:52:12 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹1,014
  • Day's High₹1,039
  • 52 Wk High₹1,032.25
  • Prev. Close₹1,020.75
  • Day's Low₹990
  • 52 Wk Low ₹580
  • Turnover (lac)132.51
  • P/E49.87
  • Face Value₹10
  • Book Value₹0
  • EPS20.47
  • Mkt. Cap (Cr.)₹1,192.01
  • Div. Yield0.05
View All Historical Data

No Record Found

No Record Found

Remus Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹1,014

Prev. Close

₹1,020.75

Turnover(Lac.)

₹132.51

Day's High

₹1,039

Day's Low

₹990

52 Week's High

₹1,032.25

52 Week's Low

₹580

Book Value

₹0

Face Value

₹10

Mkt Cap (₹ Cr.)

1,192.01

P/E

49.87

EPS

20.47

Divi. Yield

0.05

Remus Pharmaceuticals Ltd Corporate Action

7 Sep 2026

12:00 AM

AGM

Announcement Date: 07 Sep, 2026

arrow

30 Jun 2025

12:00 AM

Bonus

arrow

2 Sep 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

20 May 2026

12:00 AM

Dividend

Dividend Amount: 0.5

Record Date: 22 Sep, 2026

arrow

Remus Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Remus Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

15 Oct, 2026|06:46 PM
Mar-2026Sep-2025Jul-2025Mar-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 70.95%

Foreign: 0.00%

Indian: 70.95%

Non-Promoter- 6.11%

Institutions: 6.11%

Non-Institutions: 22.93%

Custodian: 0.00%

Read More
Share PriceShare Price

Remus Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2026Mar-2025Mar-2024Mar-2023

Equity Capital

11.78

5.89

1.47

1.09

Preference Capital

0

0

0

0

Reserves

313.93

236.33

152.08

18.05

Net Worth

325.71

242.22

153.55

19.14

Minority Interest

View Balance Sheet

No Record Found

No Record Found

No Record Found

Particulars (Rupees in Crores.)Mar-2026Mar-2025Mar-2024

Gross Sales

853.63

620.36

212.94

Excise Duty

0

0

0

Net Sales

853.63

620.36

212.94

Other Operating Income

0

0

0

Other Income

6.7

4.98

2.83

Remus Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,746.4

131.794,19,619.691,115.140.915,641.3193.23

Divis Laboratories Ltd

DIVISLAB

9,023

80.022,39,714.158910.332,974629.49

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,580

85.21,74,740.994920.744,073222.76

Zydus Lifesciences Ltd

ZYDUSLIFE

1,124.7

30.761,12,119.43339.60.092,723.5237.3

Laurus Labs Ltd

LAURUSLABS

2,036.9

126.071,10,007.57289.960.11,757.1697.2

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Remus Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman(Non Exe)&Dir(Non-Ind)

SWAPNIL JATINBHAI SHAH

Managing Director

ARPIT DEEPAKKUMAR SHAH

Whole-time Director

Roma Vinodbhai Shah

Non-Exec & Non-Independent Dir

Anar Swapnil Shah

Independent Non Exe. Director

Vishrut Chandramauli Pathak

Independent Non Exe. Director

Balwant Purohit

Independent Non Exe. Director

Sanjana Sanjeev Shah

Company Sec. & Compli. Officer

Deval Patel

Registered Office

1101 to 1103 South Tower One42,

B/H Ashok Vatika Amblibopal Rd,

Gujarat - 380054

Tel: 91-079-29999857

Website: https://www.remuspharma.com

Email: cs@remuspharma.com

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai-400083

Tel: 91-22-49186000

Website: https://in.mpms.mufg.com

Email: rnt.helpdesk@in.mpms.mufg.com

Summary

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by t...
Read More

Reports by Remus Pharmaceuticals Ltd

Company FAQs

The Remus Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1011.55 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remus Pharmaceuticals Ltd is ₹1192.01 Cr. as of 15 Oct ‘26
The PE and PB ratios of Remus Pharmaceuticals Ltd is 49.87 and 3.69 as of 15 Oct ‘26
The 52-week high/low is the highest and lowest price at which a Remus Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Remus Pharmaceuticals Ltd is ₹580 and ₹1032.25 as of 15 Oct ‘26
Remus Pharmaceuticals Ltd's CAGR for 5 Years at 35.36%, 3 Years at 15.50%, 1 Year at 48.15%, 6 Month at 60.18%, 3 Month at 42.19% and 1 Month at 15.37%.
The shareholding pattern of Remus Pharmaceuticals Ltd is as follows:
Promoters - 70.95 %
Institutions - 6.11 %
Public - 22.93 %

QUICKLINKS FOR Remus Pharmaceuticals Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.